GLENN SBLENDORIO - 04 Apr 2022 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Role: CEO, Director
Signature: /s/ Todd Anderman, as Attorney-in-Fact for Glenn P. Sblendorio
Issuer symbol: ISEE
Transactions as of: 04 Apr 2022
Transactions value $: -$937,805
Form type: 4
Filing time: 06 Apr 2022, 18:11:19 UTC
Previous filing: 01 Apr 2022
Next filing: 27 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISEE	Common Stock	Sale	-$938K	-50K	-17.88%	$18.76	230K	04 Apr 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2021, as previously disclosed in the Registrant's Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on November 9, 2021, and as described in the Registrant's Proxy Statement for its 2022 Annual Meeting of the Stockholders, as filed with the Securities and Exchange Commission on March 30, 2022. For a full discussion regarding the details of the Rule 10b5-1 trading plan adopted by the Reporting Person, refer to the Registrant's Proxy Statement for its 2022 Annual Meeting of the Stockholders, as filed with the the Securities and Exchange Commission on March 30, 2022.

Content

The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2021, as previously disclosed in the Registrant's Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on November 9, 2021, and as described in the Registrant's Proxy Statement for its 2022 Annual Meeting of the Stockholders, as filed with the Securities and Exchange Commission on March 30, 2022. For a full discussion regarding the details of the Rule 10b5-1 trading plan adopted by the Reporting Person, refer to the Registrant's Proxy Statement for its 2022 Annual Meeting of the Stockholders, as filed with the the Securities and Exchange Commission on March 30, 2022.